why choose us

First received: March 08, 2024

Clinical Trial: Tofacitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Dose Escalation Study

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Axial Spondyloarthritis

Study Type: INTERVENTIONAL


Official Title: Tofacitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Dose Escalation Study

Brief Summary: The goal of this clinical trial is to assess the efficacy of tofacitinib in refractory axial spodyloarthritis (ax-SpA) with dose escalation from 10mg to 15mg.Patients will start on 10mg and then divided into 2 groups (10 and 15) at 3rd month according to major improvement criteria.The main question[s] it aims to answer are:Efficacy and safety of tofacitinib in different dosesIf escalation of tofacitinib is justified if clinical criteria is not fulfilled at 10mg

Read more